United Therapeutics Corporation v. Liquidia Technologics, Inc.

22-2133Court of Appeals for the Federal Circuit18 nov. 2022

Texte intégral

NOTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
UNITED THERAPEUTICS CORPORATION,
Appellant
v.
LIQUIDIA TECHNOLOGICS, INC.,
Appellee
2022-2133
Appeal from the U n i t e d S t a t e s Patent and Trademark
Office, Patent Trial and Appeal Board in IPR2020-00770.
--------------------------------------------------
LIQUIDIA TECHNOLOGICS, INC.,
Appellant
v.
UNITED THERAPEUTICS CORPORATION,
Appellee
2022-2174
Case: 22-2133 Document: 28 Page: 1 Filed: 11/18/2022

-- 1 of 2 --

2 BRUMFIELD V. IBG LLC
Appeal from the U n i t e d S t a t e s Patent and Trademark
Office, Patent Trial and Appeal Board in IPR2020-00770.
ON MOTION
ORDER
Upon consideration of the party’s motion to voluntarily
dismiss Appeal No. 2022-2174,
IT IS ORDERED THAT:
(1) The motion is granted. Appeal No. 2022-2174 is
DISMISSED under Fed. R. App. P. 42 (b).
(2) Each side shall bear their own costs with respect to
Appeal No. 2022-2174.
(3) Appeal No. 2022-2174 is deconsolidated from
Appeal No. 2022-2133, and the revised caption is reflected
above.
November 18, 2022
Date
FOR THE COURT
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court
ISSUED AS A MANDATE (only as to Appeal No.
2022-2174): November 18, 2022
Case: 22-2133 Document: 28 Page: 2 Filed: 11/18/2022

-- 2 of 2 --

Poursuivez vos recherches dans ChatGPT ou Claude

Connectez Omnilex pour rechercher dans le corpus juridique depuis votre assistant IA.